TQG-2813

N/A

Report date: 2025/01/26 17:07:35

Base Information

Drug NameTQG-2813
Drug Alias NameTQG-2813
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesCryopyrin-Associated Periodic SyndromesArthritis, Juvenile +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesCryopyrin-Associated Periodic SyndromesArthritis, Juvenile +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A